Insights On Pharma Logistics
-
Global Complexity Demands Local Resilience
8/31/2026
With integrated capabilities spanning early development through commercial manufacturing, our U.S. network helps customers build greater supply chain resilience, navigate uncertainty, and create a more reliable path to market.
-
3 Decision Domains Shaping Sterile Drug Product Success
8/28/2026
In sterile development, the decisions with the greatest downstream consequences are rarely recognized as such when they are made. Examine how these choices shape program outcomes across the lifecycle.
-
Clinical Trial Logistics: What Biopharma Needs To Prepare For Next
8/17/2026
Fragmented clinical trial logistics are slowing programs and increasing risk. Learn how coordinated planning and digital visibility are becoming competitive advantages in complex, global studies.
-
Accelerating Drug Development Through Integrated CDMO And CRO Partnership
8/12/2026
Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.
-
When Every Hour Counts: Emergency Transfer Protects Critical Biomedical Materials
8/10/2026
Rapid deployment of specialized cold chain logistics and cryogenic assets ensures strict temperature compliance, protecting critical research continuity and preventing catastrophic material loss.
-
Flexibility In Drug Development: From Tactical Response To Strategic Discipline
8/10/2026
Historically managed through late-stage adjustments, operational adaptability has become a strategic imperative to prevent programs from stalling under real-world pressures.
-
Distribution Automation System For Clinical Supply Chains
7/15/2026
Automated storage and retrieval technology reduces mis-picks, speeds order processing, and keeps clinical trial materials moving on time as study demands shift.
-
Optimizing Clinical Supply Management With A One-Team Approach
7/15/2026
See how NewAmsterdam Pharma managed 11 global studies across 51 countries and 835 sites for 12,000+ patients without overwhelming their internal team.
-
5 Operational Gaps To Avoid CGT Patient Risks
5/27/2026
Examine five critical supply chain gaps in cell and gene therapy logistics that put patients at risk, from invisible operational burdens to reactive monitoring and fragmented coordination strategies.
-
An Innovative, Modular Approach To Flexible Supply Chain Management
5/15/2026
Learn how modular strategies, global coordination, and data-driven decisions help maintain continuity, compliance, and speed amid constant uncertainty.